Gene Panel Market Research Report - Global Forecast till 2030

Gene Panel Market: Information by Product & Service (Test Kits and Testing Services), By Technique (Amplicon-Based Approach and Hybridization-Based Approach), Design (Predesigned Gene Panels and Customized Gene Panels), Application (Cancer Risk Assessment, Diagnosis, and Pharmacogenetics), End User (Hospitals & Clinics, Research Organizations & Academic Institutes), Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast till 2030

ID: MRFR/LS/4642-CR | January 2020 | Region: Global | 220 Pages         

Gene Panel Market Speak to Analyst Request a Free Sample

Gene Panel Market

Global Gene Panel Market is expected to register a CAGR of 13.72% to reach USD 2.5 Billion by 2030

Segmentation
By Product & Service Test Kits Testing Services
By Technique Amplicon-Based Approach Hybridization-Based Approach
By Design Predesigned Gene Panels Customized Gene Panels
By Application Cancer Risk Assessment Diagnosis Pharmacogenetics
By End User Hospitals & Clinics Research Organizations Academic Institutes
Key Players
Companies Profiled   Agilent Technologies Inc. (U.S.)   Thermo Fisher Scientific (U.S.)   Hoffmann-La Roche Ltd (Switzerland)   Qiagen (Germany)   Illumina Inc. (U.S.)   BGI Genomics (China)   Integrated DNA Technologies    Inc. (U.S.)   GENEWIZ (U.S.)   Novogene Corporation (U.S.)   Personalis Inc. (U.S.)   GATC Biotech AG (Germany)
Drivers
Market Driving Forces   The increasing prevalence of cancer and the benefits of gene panels.   Improving the efficiency of gene panels
Request a Free Sample

Gene Panel Market Overview


The gene panel market is expected reach USD 2.5 billion by 2030 at 13.72% CAGR during the forecast 2022-2030.The various selected set of genes which is commonly used for suspecting relationship with the phenotype or disease for the study is done in gene panel market. The custom-designed or predesigned- content can be purchased by the market to include the genomic region of interest. Owing to the increasing cases of different types of cancers like breast cancer in women, cancer in ovaries, cancer in fallopian tubes, and prostate cancer in men a significant growth has been seen in the global market.


COVID 19 Analysis


The normal working lives of people have been affected adversely owing to the prevailing global pandemic situation of COVID 19 all across the globe. This situation has pushed the economies towards forced recession. The outbreak of the global pandemic of COVID 19 resulted in financial crises along with health concerns. The lockdown situation during the peak COVID 19 situation has abruptly affected the supply chain operations of the gene panel market which resulted in a steep downfall in sales revenue of the market.


However, it is expected that the market will recover from this global pandemic situation by the end of the third quarter of the coming year.


Market Dynamics


Drivers


Owing to the increasing variety in the cases of cancers in both males and females and benefits provided by the gene panel market to fight against cancer propel the market growth. Also, the increasing efficiency in the working of market is another factor that boosts the growth of the market. The advancement in technology and an increasing need for prenatal diagnosis is another contributing factor to accelerate the growth of the market.


Opportunities


The rise in the growth of demand of gene panel market in the global market. During the forecasted period, a huge investment is expected to be done by the major market key players and increasing pool of patients provides growth opportunities in the future. Investment is done by the government in the market also offers growth factor in the global market.


Restraints


The gene panel market is increasing constantly in the global market but some factors restrain its growth during the forecasted period. The stringent regulations related to establishing pharmaceutical companies and regulations related to its working hinder the growth of the market. Moreover, the safety concern regarding genetic data is another hindrance in the growth of the global market.


Value Chain Analysis


The demand for the gene panel market is increasing tremendously in the global market and hence adds value to society. The modern market helps in analyzing multiple genes for cancer mutations at the same time. The two most common genes which help in suppressing tumors are BRCA1 and BRCA2 by repairing the damaged DNA whose mutations can cause cancer and hence helps in saving the lives of many people.


Market Segmentation


The gene panel market in the global market has been divided into broader terms based on products & services, technique, design, application, and end-users.


Based on the Product & Service



  • The global market has been divided based on the product and service into testing services, test kits, and many others.


Based on the Technique



  • The global market has been divided based on the technique into hybridization-based approach technique, and amplicon-based approach technique.


Based on the Design



  • The global market has been divided based on the design into customized gene panels design, predesigned gene panel design, and many others.


Based on the Application



  • The global market has been divided based on the application into diagnosis, cancer risk assessment, pharmacogenetics, and many others.


Based on the End-Users



  • The global market has been divided based on the end-users into diagnostic laboratories, hospitals, and many others.


Regional Analysis


The gene panel market has been divided based on the region into North American region, the Middle East and African region, Asia-Pacific region, European region, and the rest of the world. The largest market share in the global market is held by the North American region and hence it dominates the global market. The growing cases of cancer patients drive the market in this region.


The second-largest market share in the global market is held by the European region as the number of cancer cases is expected to increase with a 2% growth rate in the U.K. The third-largest market share in the global market is held by the Asia-Pacific region owing to increasing expenditure on healthcare facilities by the government. The presence of a high population in the Asia-Pacific region is another contributing factor.


Competitive Landscape


The most prominent major key players in the gene panel market in the global market are mentioned below:



  • Agilent Technologies Inc. (U.S.)

  • Thermo Fisher Scientific (U.S.)

  • Hoffmann-La Roche Ltd (Switzerland)

  • Qiagen (Germany)

  • Illumina Inc. (U.S.)

  • BGI Genomics (China)

  • Integrated DNA Technologies, Inc. (U.S.)

  • GENEWIZ (U.S.)

  • Novogene Corporation (U.S.)

  • Personalis, Inc. (U.S.)

  • GATC Biotech AG (Germany)

  • ArcherDX, Inc. (U.S.)

  • GeneDX (Switzerland)

  • CENTOGENE AG (Germany)


These major market key players in the market adopt various strategies and techniques to expand in the global market by establishing a joint venture, collaboration, mergers, and acquisitions, establishing a partnership, developing a new production process, developing a new product, innovation in the existing products to expand their customer base in the untapped market.


Recent Developments



  • In June 2018, Ion AmpliSeq HD technology has been launched by Thermo Fisher Scientific that will be treated as a next-generation library which will provide custom-designed gene panels to clinical researchers to interrogate highly heterogeneous tumor samples

  • In October 2019, a 15-year partnership has been announced between Illumina and Qiagen to increase the supply of NGS-based in-vitro diagnostic (IVD) kits for proper patient management. This partnership will provide universal solutions for using the GeneReader NGS System and any sequencer for small gene panels.

  • In 2017, approximately 1,688,780 new cases of cancer got registered in the U.S. due to which the North American region holds the largest market share in the global market of gene panel. The North American region dominates the global market.

  • The GENEWIZ (U.S.) is investigating a huge amount in the research and development of the market to sustain its market position in the global market and to expand its customer base for more sales revenue.


Report Overview


This gene panel market research report consists of the following elements:



  • Market Overview

  • COVID 19 Analysis

  • Market Dynamics

  • Value Chain Analysis

  • Market Segmentation

  • Regional Analysis

  • Competitive Landscape

  • Recent Developments


This global market research report contains various factors that drive the market to greater heights in the market along with the factors that restrain its growth in the global market. The various growth opportunities available during the forecasted period in the global market are mentioned. The impact of COVID 19 on the sales revenue of the market is enumerated. The future growth rate of the market in the global market is estimated and mentioned.


Users


Pharmaceutical companies, research and development organizations, academic institutes, contract research organizations, market research and consulting service providers, and many others.



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 2.5 Billion
  CAGR   13.72%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product & Service, By Technique, Design, Application, End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Agilent Technologies Inc. (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche Ltd (Switzerland), Qiagen (Germany), Illumina Inc. (US), BGI Genomics (China), Integrated DNA Technologies, Inc. (US), GENEWIZ (US), Novogene Corporation (US), Personalis, Inc. (US), GATC Biotech AG (Germany), ArcherDX, Inc. (US), GeneDx (Switzerland), and CENTOGENE AG (Germany)
  Key Market Opportunities   Rising investments by major market players, and growing patient pool
  Key Market Drivers

  • The increasing prevalence of cancer and the benefits of gene panels.
  • Improving the efficiency of gene panels


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Gene Panel Market is projected to grow at a 13.72% CAGR between 2022-2030.

    Gene Panel Market predicted to touch USD 2.5 billion by 2030.

    The Americas is expected to lead the Gene Panel Market.

    The cancer risk assessment segment will have the largest share in the Gene Panel Market.

    Inaccuracy of the test may limit market growth.